about
Plague Vaccine Development: Current Research and Future TrendsCharacterization of systemic and pneumonic murine models of plague infection using a conditionally virulent strain.LcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague.Selective Protective Potency of Yersinia pestis ΔnlpD MutantsIntramuscular Immunization of Mice with a Live-Attenuated Triple Mutant of Yersinia pestis CO92 Induces Robust Humoral and Cell-Mediated Immunity To Completely Protect Animals against Pneumonic Plague.A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates.Rational considerations about development of live attenuated Yersinia pestis vaccinesPlague vaccines: current developments and future perspectives.
P2860
Q28066875-AC64D8E9-9DFD-4FBF-8763-4F71CBFB4600Q30414497-305778F2-64EA-4F89-A876-58700AB50F8DQ34298699-4447F302-301B-4B11-B6F6-09935DA7A6E4Q35540412-DB9270E9-4056-4B57-9413-FCF9257EDA04Q36316792-638A5084-DD42-460A-9388-6B4D1C9C62A2Q37067254-C122D6D5-F2C9-417D-A778-5A4879FFE292Q37688618-FD2DE88D-3BD5-440E-A4A5-ECB116622F84Q38514208-F1055B0C-93FE-4504-93DC-4FEBC024DF0A
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 September 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Developing live vaccines against plague.
@en
Developing live vaccines against plague.
@nl
type
label
Developing live vaccines against plague.
@en
Developing live vaccines against plague.
@nl
prefLabel
Developing live vaccines against plague.
@en
Developing live vaccines against plague.
@nl
P2093
P2860
P356
P1476
Developing live vaccines against plague
@en
P2093
Kenneth L Roland
Roy Curtiss
P2860
P304
P356
10.3855/JIDC.2030
P407
P577
2011-09-14T00:00:00Z